06 July 2017

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, is pleased to announce that at the Company's Annual General Meeting held earlier today, 6 July 2017, all resolutions put to the meeting were duly passed.

For further information:

Quantum Pharma Plc
Chris Rigg, Chief Executive Officer Tel: +44 (0) 1207 279 404
Gerard Murray, Chief Financial Officer www.quantumpharmagroup.com
ir@quantumpharma.co.uk
N+1 Singer
(Nominated Advisor & Broker)
Sandy Fraser / Nick Owen / James White Tel: +44 (0) 20 7496 3000
Media enquiries:
Buchanan
Henry Harrison-Topham / Sophie Cowles Tel: +44 (0) 20 7466 5000
quantumpharma@buchanan.uk.com www.buchanan.uk.com

Notes to Editors

Quantum Pharma Plc is a service-led, niche pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesale and hospital markets. Quantum Pharma Plc operates through two divisions - Specials and Niche Pharmaceuticals - offering a portfolio of innovative and complementary products and services.

For further information, please visit www.quantumpharmagroup.com.

Quantum Pharma plc published this content on 06 July 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 06 July 2017 12:55:10 UTC.

Original documenthttp://ir.quantumpharmagroup.com/content/news/news_archive/2017/06-07-17.asp

Public permalinkhttp://www.publicnow.com/view/27A2B1C6908DB57345465C41AF8BDA8A8D024BE2